Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
4.960
-1.040 (-17.33%)
At close: Jun 12, 2026, 4:00 PM EDT
4.970
+0.010 (0.20%)
After-hours: Jun 12, 2026, 7:59 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $830.65 thousand as of June 12, 2026. Its market cap has decreased by -97.18% in one year.
Market Cap
830.65K
Enterprise Value
-3.53M
1-Year Change
-97.18%
Ranking
Category
Stock Price
$4.96
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.64M to $830.65K, a decrease of -99.76%. That is a compound annual growth rate of -76.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 830.65K | -94.14% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.29M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.15M | 5.86% |
| Apr 11, 2022 | 349.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 2.60M |
| Ensysce Biosciences | 2.44M |
| Biodexa Pharmaceuticals | 2.30M |
| Bone Biologics | 2.28M |
| Propanc Biopharma | 2.03M |
| Valion Bio | 1.88M |
| Jaguar Health | 1.70M |
| Silexion Therapeutics | 1.29M |